SN-40318

N/A

Report date: 2024/12/30 15:53:09
NME

Base Information

Drug NameSN-40318
Drug Alias NameSN-40318SN40318
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-dependent protein kinase inhibitors
TargetsDNA-dependent protein kinase
Therapy Area/IndicationsSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Auckland
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Auckland
Inactive CompaniesN/A
Active IndicationsSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A